153 related articles for article (PubMed ID: 35445401)
1. Valosin-containing protein regulates the stability of fused in sarcoma granules in cells by changing ATP concentrations.
Yasuda K; Watanabe TM; Kang MG; Seo JK; Rhee HW; Tate SI
FEBS Lett; 2022 Jun; 596(11):1412-1423. PubMed ID: 35445401
[TBL] [Abstract][Full Text] [Related]
2. Interaction of amyotrophic lateral sclerosis/frontotemporal lobar degeneration-associated fused-in-sarcoma with proteins involved in metabolic and protein degradation pathways.
Wang T; Jiang X; Chen G; Xu J
Neurobiol Aging; 2015 Jan; 36(1):527-35. PubMed ID: 25192599
[TBL] [Abstract][Full Text] [Related]
3. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.
Neumann M; Bentmann E; Dormann D; Jawaid A; DeJesus-Hernandez M; Ansorge O; Roeber S; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ang LC; Bilbao J; Rademakers R; Haass C; Mackenzie IR
Brain; 2011 Sep; 134(Pt 9):2595-609. PubMed ID: 21856723
[TBL] [Abstract][Full Text] [Related]
4. Cdc48/VCP and Endocytosis Regulate TDP-43 and FUS Toxicity and Turnover.
Liu G; Byrd A; Warner AN; Pei F; Basha E; Buchanan A; Buchan JR
Mol Cell Biol; 2020 Jan; 40(4):. PubMed ID: 31767634
[TBL] [Abstract][Full Text] [Related]
5. How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other?
Baloh RH
Curr Opin Neurol; 2012 Dec; 25(6):701-7. PubMed ID: 23041957
[TBL] [Abstract][Full Text] [Related]
6. Autophagy regulates amyotrophic lateral sclerosis-linked fused in sarcoma-positive stress granules in neurons.
Ryu HH; Jun MH; Min KJ; Jang DJ; Lee YS; Kim HK; Lee JA
Neurobiol Aging; 2014 Dec; 35(12):2822-2831. PubMed ID: 25216585
[TBL] [Abstract][Full Text] [Related]
7. Fused in sarcoma (FUS): an oncogene goes awry in neurodegeneration.
Dormann D; Haass C
Mol Cell Neurosci; 2013 Sep; 56():475-86. PubMed ID: 23557964
[TBL] [Abstract][Full Text] [Related]
8. FUS is lost from nuclei and gained in neurites of motor neurons in a human stem cell model of VCP-related ALS.
Harley J; Hagemann C; Serio A; Patani R
Brain; 2020 Dec; 143(12):e103. PubMed ID: 33253377
[No Abstract] [Full Text] [Related]
9. Stress granules in neurodegeneration--lessons learnt from TAR DNA binding protein of 43 kDa and fused in sarcoma.
Bentmann E; Haass C; Dormann D
FEBS J; 2013 Sep; 280(18):4348-70. PubMed ID: 23587065
[TBL] [Abstract][Full Text] [Related]
10. Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43).
Bentmann E; Neumann M; Tahirovic S; Rodde R; Dormann D; Haass C
J Biol Chem; 2012 Jun; 287(27):23079-94. PubMed ID: 22563080
[TBL] [Abstract][Full Text] [Related]
11. ATP enhances at low concentrations but dissolves at high concentrations liquid-liquid phase separation (LLPS) of ALS/FTD-causing FUS.
Kang J; Lim L; Song J
Biochem Biophys Res Commun; 2018 Oct; 504(2):545-551. PubMed ID: 30205960
[TBL] [Abstract][Full Text] [Related]
12. Altered mRNP granule dynamics in FTLD pathogenesis.
Bowden HA; Dormann D
J Neurochem; 2016 Aug; 138 Suppl 1():112-33. PubMed ID: 26938019
[TBL] [Abstract][Full Text] [Related]
13. ALS mutations of FUS suppress protein translation and disrupt the regulation of nonsense-mediated decay.
Kamelgarn M; Chen J; Kuang L; Jin H; Kasarskis EJ; Zhu H
Proc Natl Acad Sci U S A; 2018 Dec; 115(51):E11904-E11913. PubMed ID: 30455313
[TBL] [Abstract][Full Text] [Related]
14. TDP-43 and FUS/TLS: cellular functions and implications for neurodegeneration.
Fiesel FC; Kahle PJ
FEBS J; 2011 Oct; 278(19):3550-68. PubMed ID: 21777389
[TBL] [Abstract][Full Text] [Related]
15. An autopsy report of a familial amyotrophic lateral sclerosis case carrying VCP Arg487His mutation with a unique TDP-43 proteinopathy.
Matsubara T; Izumi Y; Oda M; Takahashi M; Maruyama H; Miyamoto R; Watanabe C; Tachiyama Y; Morino H; Kawakami H; Saito Y; Murayama S
Neuropathology; 2021 Apr; 41(2):118-126. PubMed ID: 33415820
[TBL] [Abstract][Full Text] [Related]
16. Casein kinase 1δ/ε phosphorylates fused in sarcoma (FUS) and ameliorates FUS-mediated neurodegeneration.
Kishino Y; Matsukawa K; Matsumoto T; Miyazaki R; Wakabayashi T; Nonaka T; Kametani F; Hasegawa M; Hashimoto T; Iwatsubo T
J Biol Chem; 2022 Aug; 298(8):102191. PubMed ID: 35753345
[TBL] [Abstract][Full Text] [Related]
17. Roles of ataxin-2 in pathological cascades mediated by TAR DNA-binding protein 43 (TDP-43) and Fused in Sarcoma (FUS).
Nihei Y; Ito D; Suzuki N
J Biol Chem; 2012 Nov; 287(49):41310-23. PubMed ID: 23048034
[TBL] [Abstract][Full Text] [Related]
18. Monomethylated and unmethylated FUS exhibit increased binding to Transportin and distinguish FTLD-FUS from ALS-FUS.
Suárez-Calvet M; Neumann M; Arzberger T; Abou-Ajram C; Funk E; Hartmann H; Edbauer D; Kremmer E; Göbl C; Resch M; Bourgeois B; Madl T; Reber S; Jutzi D; Ruepp MD; Mackenzie IR; Ansorge O; Dormann D; Haass C
Acta Neuropathol; 2016 Apr; 131(4):587-604. PubMed ID: 26895297
[TBL] [Abstract][Full Text] [Related]
19. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins.
Ratti A; Buratti E
J Neurochem; 2016 Aug; 138 Suppl 1():95-111. PubMed ID: 27015757
[TBL] [Abstract][Full Text] [Related]
20. Transportin 1 accumulates specifically with FET proteins but no other transportin cargos in FTLD-FUS and is absent in FUS inclusions in ALS with FUS mutations.
Neumann M; Valori CF; Ansorge O; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ishihara K; Ang LC; Bilbao JM; Mackenzie IR
Acta Neuropathol; 2012 Nov; 124(5):705-16. PubMed ID: 22842875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]